COMMUNIQUÉ DE PRESSE publié le 15/05/2026 à 13:45, il y a 2 mois 13 jours Mako Mining Reports Q1 2026 Financial Results, Including Adjusted EBITDA(1) of US$40.1 Million and EPS of US$0.26/Share Mako Mining Corp. reports record financial results for Q1 2026, including $68.6M revenue, $40.1M Adjusted EBITDA, and $23.1M Net Income. Focus on profitability and growth trajectory Financial Results Profitability Mako Mining Corp. Growth Trajectory Q1 2026
COMMUNIQUÉ DE PRESSE publié le 15/05/2026 à 13:45, il y a 2 mois 13 jours Digi Power X Reports First Quarter 2026 Financial Results Digi Power X Inc. reports Q1 2026 financial results with first AI revenues, $125M cash, zero long-term debt, and $45M capex deployed at Columbiana. NeoCloudz GPU Cloud Live Financial Results Q1 2026 Digi Power X AI Revenues NeoCloudz GPU Cloud
COMMUNIQUÉ DE PRESSE publié le 15/05/2026 à 13:04, il y a 2 mois 13 jours Technip Energies reçoit l’autorisation définitive pour l’exécution d’un contrat EPC majeur avec Commonwealth LNG aux États-Unis Technip Energies obtient l'autorisation finale pour un contrat EPC majeur avec Commonwealth LNG pour un projet de GNL aux États-Unis, renforçant sa position en tant que leader mondial du GNL GNL Contrat EPC Technip Energies Commonwealth LNG Autorisation Finale
COMMUNIQUÉ DE PRESSE publié le 15/05/2026 à 13:04, il y a 2 mois 13 jours Technip Energies receives Full Notice To Proceed on major EPC contract with Commonwealth LNG in the United States Technip Energies receives Full Notice To Proceed on major EPC contract with Commonwealth LNG for LNG export facility in Louisiana, US EPC Contract Technip Energies Commonwealth LNG Full Notice To Proceed LNG Export Facility
COMMUNIQUÉ DE PRESSE publié le 15/05/2026 à 13:00, il y a 2 mois 13 jours Sandoz confirms European Commission approval for biosimilars Bysumlog® (insulin lispro) and Dazparda® (insulin aspart), strengthening position in diabetes Sandoz Group AG confirms European Commission approval for biosimilars Bysumlog(R) (insulin lispro) and Dazparda(R) (insulin aspart), strengthening position in diabetes Diabetes Biosimilars European Commission Approval Sandoz Group AG Insulin Treatment
COMMUNIQUÉ DE PRESSE publié le 15/05/2026 à 13:00, il y a 2 mois 13 jours Gold Terra Adds 595,000 Inferred Ounces within 5.1 Million Tonnes grading 3.64 g/t Au on the Con Mine Zone 103N in an Updated 2026 Mineral Resource Estimate, Yellowknife, NWT Gold Terra Resource Corp. announces 2026 updated Mineral Resource Estimate for Yellorex, Zone 103N, and Crestaurum deposits on Yellowknife Project. Includes exploration plans and future MRE updates Mineral Resource Estimate Exploration Drilling Program Gold Terra Yellowknife Project
COMMUNIQUÉ DE PRESSE publié le 15/05/2026 à 12:47, il y a 2 mois 13 jours REPLY: The Board of Directors approves the quarterly report dated 31 March 2026 Reply S.p.A. Board of Directors approves strong quarterly results for March 31, 2026, with growth in revenues, EBITDA, EBIT, and profit before tax Revenues EBITDA Quarterly Results Reply S.p.A. Profit Before Tax
COMMUNIQUÉ DE PRESSE publié le 15/05/2026 à 12:10, il y a 2 mois 13 jours SouthGobi Announces Update on Upcoming Annual and Special Meeting Of Shareholders SouthGobi Resources Ltd. provides an update on its annual and special meeting of shareholders, rescheduling the approval of the March 2026 Deferral Agreement to a Special Meeting Shareholders Special Meeting SouthGobi Resources Ltd. Annual Meeting March 2026 Deferral Agreement
COMMUNIQUÉ DE PRESSE publié le 15/05/2026 à 12:07, il y a 2 mois 13 jours Original-Research: Almonty Industries Inc. (von Sphene Capital GmbH): Buy Sphene Capital GmbH upgrades Almonty Industries Inc., raising target price to CAD 37.40 from CAD 20.10. Q1/2026 revenue triples to CAD 25.4 mn. Buy rating reiterated with 48.4% upside potential Revenue Increase BUY Rating Target Price Sphene Capital GmbH Almonty Industries Inc.
COMMUNIQUÉ DE PRESSE publié le 15/05/2026 à 11:56, il y a 2 mois 13 jours Invitation to the Annual General Meeting on 16 June 2026 Befesa S.A. convenes Annual General Meeting & Extraordinary General Meeting on 16 June 2026 for various agenda items including financial statements approval & director re-appointments Annual General Meeting Financial Statements Extraordinary General Meeting Befesa S.A. Director Re-appointments
Publié le 29/07/2026 à 08:00, il y a 20 minutes Neoen doubles size of Goyder Battery after signing two 15-year capacity contracts in South Australia
Publié le 29/07/2026 à 08:00, il y a 20 minutes Neoen double la capacité de Goyder Battery après avoir remporté deux contrats en South Australia
Publié le 28/07/2026 à 19:21, il y a 12 heures 59 minutes Saint-Gobain signs a framework agreement with Microsoft and enhances its leadership in AI for construction
Publié le 28/07/2026 à 19:21, il y a 12 heures 59 minutes Saint-Gobain signe un accord-cadre avec Microsoft et renforce son leadership dans l’Intelligence Artificielle pour la construction
Publié le 28/07/2026 à 18:25, il y a 13 heures 55 minutes ACCOR - Finalisation de la 1ere tranche du programme de rachat d'action
Publié le 29/07/2026 à 08:05, il y a 15 minutes Tocvan Announces Strategic Management Restructuring to Align Leadership with Growth and Production Objectives
Publié le 29/07/2026 à 04:38, il y a 3 heures 42 minutes CoTec Holdings Corp. Engages Epstein Research
Publié le 28/07/2026 à 23:13, il y a 9 heures 7 minutes Nepra Foods Executes Definitive Agreement to Acquire Idaho Beverage Manufacturing Business
Publié le 28/07/2026 à 22:05, il y a 10 heures 15 minutes Unusual Machines Adopts Performance-Based Executive Compensation
Publié le 29/07/2026 à 08:00, il y a 20 minutes CookieYes Named Exclusive Consent Management Partner for Cloudways
Publié le 29/07/2026 à 07:30, il y a 50 minutes VINCORION Records More Than EUR 100 Million in Order Intake in June 2026
Publié le 29/07/2026 à 07:30, il y a 50 minutes AUTO1 Group reports strong Q2 2026 unit and profitability growth
Publié le 29/07/2026 à 07:30, il y a 50 minutes Porsche AG achieves further milestones and stabilises profitability
Publié le 29/07/2026 à 07:30, il y a 50 minutes Befesa delivers strong Q2 2026, adjusted EBITDA up 17% to €66m reaffirming the outlook for the full year